Wave Life Sciences (WVE) Enterprise Value (2016 - 2025)
Wave Life Sciences' Enterprise Value history spans 11 years, with the latest figure at -$602.1 million for Q4 2025.
- For Q4 2025, Enterprise Value fell 99.32% year-over-year to -$602.1 million; the TTM value through Dec 2025 reached -$602.1 million, down 99.32%, while the annual FY2025 figure was -$602.1 million, 99.32% down from the prior year.
- Enterprise Value reached -$602.1 million in Q4 2025 per WVE's latest filing, down from -$196.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$88.5 million in Q4 2022 to a low of -$602.1 million in Q4 2025.
- Average Enterprise Value over 5 years is -$197.8 million, with a median of -$163.5 million recorded in 2023.
- Peak YoY movement for Enterprise Value: surged 42.74% in 2021, then tumbled 126.39% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$150.6 million in 2021, then soared by 41.22% to -$88.5 million in 2022, then plummeted by 126.39% to -$200.4 million in 2023, then crashed by 50.77% to -$302.1 million in 2024, then plummeted by 99.32% to -$602.1 million in 2025.
- Per Business Quant, the three most recent readings for WVE's Enterprise Value are -$602.1 million (Q4 2025), -$196.2 million (Q3 2025), and -$208.5 million (Q2 2025).